Microsoft to Lay Off 3% of Global Workforce
May 14, 2025: Microsoft has announced plans to reduce its global workforce by approximately 3%, affecting roughly 10,000 employees across multiple departments.
- May 20, 2025 12:56 pm
- California
April 5, 2021:-There are signs that Europe’s diverging and changing its usage rules when it comes to the AstraZeneca COVID-19 shot, and the University of Oxford is sowing more confusions among citizens.
Not only have EU citizens had to contend with a barrage of negative sentiment toward the vaccine, even from top officials themselves, but they’ve also seen the doses suspended by over a dozen European countries with the concerns over a small number of reports of blood clots.
Following safety reviews of the data, the European Medicines Agency and World Health Organization recommended continued use of the dose, saying its benefits outweighed possible risks. But the fears are still present, with confusion now reigning over which age group should, and can, take the vaccine.
On Tuesday, Germany suspended the use of the AstraZeneca shot in all people below 60, citing renewed concerns after a small number of reports of severe blood clots. Earlier this week, some Berlin hospitals had initially stopped vaccinating women below 55 with AstraZeneca’s dose.
Germany had only permitted the vaccine to be used in the under-65s initially, as there was not enough data to show it was safe and effective for the elder citizen. However, it reversed that decision in early March.
On Wednesday, Spain also decided to extend the vaccine to essential workers over 65 years old. Until then, the vaccine had been restricted to the 55-to-65 age group but will now be available to priority groups in that age group like health workers, police officers, or teachers.
In France, the AstraZeneca vaccine was not permitted for the over-65s in the beginning, with French President Emmanuel Macron, now criticized for his armchair epidemiology by many French commentators erroneously that the vaccine was “quasi-ineffective” for the over-65s.
Regarding administering the second vaccine dose to younger people who have already received the first dose of the AstraZeneca vaccine, Germany’s vaccine committee said it would issue guidance on the matter by this month’s end.
Only 10% of Europe’s total population has received one vaccine dose to date, and 4% have completed an entire vaccine series, according to data compiled by WHO.
The United Nations health agency has described the region’s vaccine rollout as “unacceptably slow.”
We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.
May 14, 2025: Microsoft has announced plans to reduce its global workforce by approximately 3%, affecting roughly 10,000 employees across multiple departments.
May 13, 2025: The Trump administration is considering suspending the constitutional right of habeas corpus in a bid to accelerate mass deportations.
April 29, 2025: Donald Trump’s second term has reached the 100-day mark under sustained public skepticism, with national approval ratings
April 24, 2025: NATO closely monitors a series of Russian naval exercises in the northern waters near Finland and Norway amid heightened military activity
April 23, 2025: The U.S. Supreme Court is preparing to issue a ruling on whether AI-generated political speech is protected under the First Amendment
Manufacturers often struggle with generating accurate and timely quotes, delaying customer responses and risking profitability. Traditional quoting processes can take days or even weeks, while customers expect responses within 24 hours. Micro Estimating Systems addresses these challenges with advanced software that allows users to generate highly accurate quotes in minutes. By integrating with shop-specific data and automating feature recognition, their solutions ensure precision and speed, empowering manufacturers to make informed decisions and enhance their operational efficiency.